Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02239263 · ClinicalTrials.gov registry record · NA
N6 Input Processing in Traditional CI Recipients
A NA study, sponsored by Cochlear.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT02239263 is a NA study that has completed, run by Cochlear. The registered enrollment target is 40 participants.
The verdict
NCT02239263, a NA study, has completed, sponsored by Cochlear.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the enhanced signal processing features of the Nucleus 6 Sound Processor on existing Nucleus cochlear implant recipients currently using the Nucleus 5 Sound Processor.
Interventions
- DEVICE Nucleus 6 Sound Processor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2014-05 |
| Est. Completion | 2015-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02239263
The ClinicalTrials.gov registry entry for NCT02239263 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cochlear, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nucleus 6 Sound Processor is the first listed.
NCT02239263 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02239263 about?
NCT02239263 is a clinical study titled "N6 Input Processing in Traditional CI Recipients". The purpose of this study is to evaluate the enhanced signal processing features of the Nucleus 6 Sound Processor on existing Nucleus cochlear implant recipients currently using the Nucleus 5 Sound Processor.
What is the current status of trial NCT02239263?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2014-05. Estimated completion is 2015-01.
What interventions are being tested in trial NCT02239263?
The interventions under investigation include: Nucleus 6 Sound Processor (DEVICE).
Who is sponsoring clinical trial NCT02239263?
This trial is sponsored by Cochlear, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.